NEUROCHEMICAL MECHANISMS OF VISCERAL PAIN
内脏疼痛的神经化学机制
基本信息
- 批准号:6187142
- 负责人:
- 金额:$ 25.58万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1999
- 资助国家:美国
- 起止时间:1999-08-01 至 2002-07-31
- 项目状态:已结题
- 来源:
- 关键词:AMPA receptors NMDA receptors behavior test brain electrical activity brain mapping central neural pathway /tract colon dorsal horn gastrointestinal sign /symptom histochemistry /cytochemistry inflammation inhibitor /antagonist laboratory rat neural information processing neuropharmacology pain pain threshold protooncogene sensory receptors single cell analysis visceral afferent nerve
项目摘要
DESCRIPTION: (adapted from applicant's abstract) In contrast to pain of somatic
origin, visceral pain has been less well studied and is poorly understood.
Separate afferents encode noxious and nonnoxious somatic stimuli. However, most
mechanosensitive colonic afferents respond to both noxious and innocuous
mechanical stimuli and virtually all mechanosensitive colonic afferents
response with thresholds below those considered painful. This application
proposes to study the physiology, pharmacology and anatomy of spinal cord
neurons that respond to nonnoxious and/or noxious colonic stimuli in order to
examine potential strategies the nervous system uses to differentiate painful
from nonpainful stimulation of the lower bowl. The long-term goal of this
application is to yield a better understanding of the spinal mechanisms that
produce visceral sensation in the hope of developing better therapeutic
regimens for visceral pain management and ultimately the alleviation of
visceral pain syndromes. A well characterized model of visceral stimulation,
colorectal distention (CRD), will be used to deliver noxious or nonnoxious
intensities of visceral stimulation. Behavioral, anatomical and
electrophysiological techniques will be used to test several alternative,
though mot mutually exclusive hypotheses in the following specific aims: 1)
Test the hypothesis that behavioral and reflex responses to noxious and
nonnoxious CRD in awake rats are differentiated, in part, by differences in the
relative amount of activity at NMDA, AMPA and NK-1 receptors and that
inflammation shifts the contribution of the receptors from the nonnoxious state
to the noxious state. 2) Test the hypothesis that the population of neurons
that responds to noxious CRD can be differentiated from the population of
neurons that responds to nonnoxious CRD on the basis of receptor content. 3)
Test the hypothesis that the differentiation of noxious from nonnoxious CRD
depends on the number and target of supraspinal projection neurons. 4) Test the
hypothesis that the temporal response of dorsal horn neurons contributes to the
differentiation of noxious and nonnoxious CRD. Demonstrate that neurons with
different temporal response profiles project to different supraspinal targets
and the pharmacology of these responses differs to noxious and nonnoxious
stimuli.
描述:(改编自申请人的摘要)与躯体疼痛相反
起源,内脏疼痛的研究较少,理解不足。
单独的传入编码有害和无毒的体细胞刺激。但是,大多数
机械敏感的结肠传入对有害和无害的反应
机械刺激和几乎所有机械敏感的结肠传入
阈值低于那些被认为是痛苦的阈值。此应用程序
建议研究脊髓的生理,药理学和解剖学
对无害和/或有害的结肠刺激反应的神经元
检查神经系统用来区分痛苦的潜在策略
从下碗的非刺激刺激。这个长期目标
应用是为了更好地了解脊柱机制
产生内脏的感觉,以期发展更好的治疗性
内脏疼痛管理方案,最终减轻
内脏疼痛综合征。良好的内脏刺激模型,
结直肠延伸(CRD)将用于提供有害或无情的
内脏刺激的强度。行为,解剖和
电生理技术将用于测试几种替代方案
尽管以下特定目的中的MoT互斥假设:1)
检验以下假设,即行为和反射对有害和的反应
醒着大鼠中无氧化的CRD部分是通过差异来区分的
NMDA,AMPA和NK-1受体的相对活性量,
炎症转移了受体的贡献
到有害状态。 2)检验神经元种群的假设
对有害的CRD做出回应的人可以与
根据受体含量对无氧化CRD反应的神经元。 3)
检验以下假设,即有害与无害CRD的分化
取决于脊柱上投影神经元的数量和靶标。 4)测试
假设背角神经元的时间反应有助于
有害和无害的CRD的差异。证明神经元与
不同的时间响应概况项目针对不同的脊柱上近视目标
这些反应的药理学不同于有害和无害的
刺激。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
RICHARD J Traub其他文献
RICHARD J Traub的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('RICHARD J Traub', 18)}}的其他基金
相似国自然基金
NMDA受体与HCN通道耦联介导噪声所致听觉中枢损伤
- 批准号:82301308
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
犬尿氨酸代谢通路异常激活NMDA受体参与老年期抑郁症认知受损的机制研究
- 批准号:82301725
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于微流控和稳转细胞模型技术检测抗NMDA受体抗体的新方法研究
- 批准号:82301527
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于NMDA受体调节探讨维生素K2在宫内缺氧所致仔鼠心肌线粒体损伤的保护作用及机制
- 批准号:82301940
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
新型NMDA受体部分激动剂GW201抗抑郁作用的机制研究
- 批准号:82273905
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
相似海外基金
Therapeutic Efficacy of Ketamine Metabolites for Depression Treatment
氯胺酮代谢物治疗抑郁症的疗效
- 批准号:
9502214 - 财政年份:2017
- 资助金额:
$ 25.58万 - 项目类别:
Therapeutic Efficacy of Ketamine Metabolites for Depression Treatment
氯胺酮代谢物治疗抑郁症的疗效
- 批准号:
9417095 - 财政年份:2016
- 资助金额:
$ 25.58万 - 项目类别:
Therapeutic Efficacy of Ketamine Metabolites for Depression Treatment
氯胺酮代谢物治疗抑郁症的疗效
- 批准号:
9314708 - 财政年份:2016
- 资助金额:
$ 25.58万 - 项目类别:
Glutamatergic transmission within the sensory ganglion
感觉神经节内的谷氨酸传输
- 批准号:
8627218 - 财政年份:2013
- 资助金额:
$ 25.58万 - 项目类别:
Glutamatergic transmission within the sensory ganglion
感觉神经节内的谷氨酸传输
- 批准号:
8510327 - 财政年份:2013
- 资助金额:
$ 25.58万 - 项目类别: